Sepsis in the Pediatric Cardiac Intensive Care Unit

World Journal for Pediatric and Congenital Heart Surgery

Volumn 2, Issue 3, 2011, Pages 393-399

  Wheeler, Derek S ^a,b,c   Jeffries, Howard E ^d   Zimmerman, Jerry J ^d   Wong, Hector R ^a,b,c   Carcillo, Joseph A ^e,f  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

congenital heart disease; immunoparalysis; pediatric cardiac surgery; pediatrics; PIRO; sepsis; septic shock; severe sepsis; systemic inflammatory response syndrome (SIRS)

Indexed keywords

EID: 84992810618     PISSN: 21501351     EISSN: 21500136     Source Type: Journal    
DOI: 10.1177/2150135111403781     Document Type: Article

References (80)

1. Bone RC Fisher CJ Clemmer TP Slotman GJ Metz CA Balk RA. Sepsis syndrome: a valid clinical entity. Crit Care Med. 1989; 17(5):389–393.
2. ACCP SCCM. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20(6):864–874.
3. Goldstein B Giroir B Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6(1):2–8.
4. Hadzimuratovic E Dinarevic SM Hadzimuratovic A. Sepsis in premature newborns with congenital heart disease. Congenit Heart Dis. 2010; 5(5):435–438.
5. Doell C Bernet V Molinari L Beck I Balmer C Latal B. Children with genetic disorders undergoing open-heart surgery: are they at increased risk for postoperative complications? Pediatr Crit Care Med. 2010;
6. Barker GM O’Brien SM Welke KF, et al. Major infection after pediatric cardiac surgery: a risk estimation model. Ann Thorac Surg. 2010; 89(3):843–850.
7. Levy I Ovadia B Erez E, et al. Nosocomial infections after cardiac surgery in infants and children: incidence and risk factors. J Hosp Infect. 2003; 53(2):111–116.
8. Sarikivi E Lyytikainen O Nieminen H Sairanen H Saxén H. Nosocomial infections after pediatric cardiac surgery. Am J Infect Control. 2008; 36(8):564–569.
9. Mehta PA Cunningham CK Colella CB Alferis G Weiner LB. Risk factors for sternal wound and other infections in pediatric cardiac surgery patients. Pediatr Infect Dis J. 2000; 19(10):1000–1004.
10. Chakrabarti C Sood SK Parnell V Rubin LG. Prolonged candidemia in infants following surgery for congenital heart disease. Infect Control Hosp Epidemiol. 2003; 24(10):753–757.
11. San Miguel LG Cobo J Otheo E, et al. Candidemia in pediatric patients with congenital heart disease. Diagn Microbiol Infect Dis. 2006; 55(3):203–207.
12. Abou Elella R Najm HK Balkhy H, et al. Impact of bloodstream infection on the outcome of children undergoing cardiac surgery. Pediatr Cardiol. 2010; 31(4):483–489.
13. Lomtadze M Chkhaidze M Mgeladze E Metreveli I Tsintsadze A. Incidence and risk factors of nosocomial infections after cardiac surgery in Georgian population with congenital heart diseases. Georgian Med News. 2010; 178: 7–11.
14. Tang CW Liu PY Huang YF, et al. Ventilator-associated pneumonia after pediatric cardiac surgery in southern Taiwan. J Microbiol Immunol Infect. 2009; 42(5):413–419.
15. Marshall JC. SIRS and MODS: What is their relevance to the science and practice of intensive care? Shock. 2000; 14(6):586–589.
16. Baue AE. A debate on the subject “Are SIRS and MODS important entities in the clinical evaluation of patients?” The con position. Shock. 2000; 14(6):590–593.
17. Vincent JL. Dear SIRS, I’m sorry to say that I don’t like you. Crit Care Med. 1997; 25(2):372–374.
18. Levy MM Fink MP Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003; 31(4):1250–1256.
19. Denoix PX. Enquete permanent dans les centres anticancereaux. Bull Inst Natl Hyg. 1946; 1(5):70–75.
20. Opal SM. Concept of PIRO as a new conceptual framework to understand sepsis. Pediatr Crit Care Med. 2005; 6(3 suppl):S55–S60.
21. Howell MD Talmor D Schuetz P Hunziker S Jones AE Shapiro NI. Proof of principle: The predisposition, infection, response, organ failure sepsis staging system. Crit Care Med. 2011; 39(2):322–327.
22. Moreno RP Metnitz B Adler L, et al. Sepsis mortality prediction based on predisposition, infection, and response. Intensive Care Med. 2008; 34(3):496–504.
23. Rubulotta F Marshall J Ramsay G Nelson D Levy M Williams M. Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsis. Crit Care Med. 2009; 37(4):1329–1335.
24. Rello J Rodriguez A Lisboa T Gallego M Lujan M Wunderink R. PIRO score for community-acquired pneumonia: A new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia. Crit Care Med. 2009; 37(2):456–462.
25. Watson RS Carcillo JA Linde-Zwirble WT Clermont G Lidicker J Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003; 167(5):695–701.
26. Angus DC Linde-Zwirble WT Lidicker J Clermont G Carcillo J Pinsky MR. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29(7):1303–1310.
27. Wynn J Cornell TT Wong HR, et al. The host response to sepsis and developmental impact. Pediatrics. 2010; 125(5):1031–1041.
28. Marriott I Huet-Hudson YM. Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res. 2006; 34(3):177–192.
29. Choudhry MA Bland KI Chaudry IH. Trauma and immune response–effect of gender differences. Injury. 2007; 38(12):1382–1391.
30. Carcillo JA. Reducing the global burden of sepsis in infants and children: A clinical practice research agenda. Pediatr Crit Care Med. 2005; 6(3 suppl):S157–S164.
31. Nguyen TH Nguyen TL Lei HY, et al. Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. Am J Trop Med Hyg. 2005; 72(4):370–374.
32. Sakr Y Madl C Filipescu D, et al. Obesity is associated with increased morbidity but not mortality in critically ill patients. Intensive Care Med. 2008; 34(11):1999–2009.
33. Wheeler DS Zingarelli B Wheeler WJ Wong HR. Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response. Recent Pat Inflamm Allergy Drug Discov. 2009; 3(2):96–112.
34. Dahmer MK Randolph A Vitali S Quasney MW. Genetic polymorphisms in sepsis. Pediatr Crit Care Med. 2005; 6(3 suppl):S61–S73.
35. Cuadrado E Barrena MJ. Immune dysfunction in Down’s syndrome: primary immune deficiency or early sensescence of the immune system? Clin Immunol Immunopathol. 1996; 78(3):209–214.
36. Nespoli L Burgio GR Ugazio AG Maccario R. Immunological features of Down’s syndrome: a review. J Intellect Disabil Res. 1993; 37(pt 6):543–551.
37. Frid C Anneren G Rasmussen F Sundelin C Drott P. Utilization of medical care among children with Down’s syndrome. J Intellect Disabil Res. 2002; 46(pt 4):310–317.
38. Garrison MM Jeffries H Christakis DA. Risk of death for children with Down syndrome and sepsis. J Pediatr. 2005; 147(6):748–752.
39. Eltzschig HK Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011; 364(7):656–665.
40. Costello JM Graham DA Morrow DF Potter-Bynoe G Sandora TJ Laussen PC. Risk factors for central line-associated bloodstream infection in a pediatric cardiac intensive care unit. Pediatr Crit Care Med. 2009; 10(4):453–459.
41. Costello JM Morrow DF Graham DA Potter-Bynoe G Sandora TJ Laussen PC. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics. 2008; 121(5):915–923.
42. Wylie MC Graham DA Potter-Bynoe G, et al. Risk factors for central line-associated bloodstream infection in pediatric intensive care units. Infect Control Hosp Epidemiol. 2010; 31(10):1049–1056.
43. Costello JM Graham DA Morrow DF, et al. Risk factors for surgical site infection after cardiac surgery in children. Ann Thorac Surg. 2010; 89(6):1833–1842.
44. Tarnok A Schneider P. Pediatric cardiac surgery with cardiopulmonary bypass: pathways contributing to transient systemic immune suppression. Shock. 2001; 16(suppl 1):24–32.
45. Allen ML Hoschtitzky JA Peters MJ, et al. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit Care Med. 2006; 34(10):2658–2665.
46. Allen ML Peters MJ Goldman A, et al. Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med. 2002; 30(5):1140–1145.
47. Cavaillon J-M Adrie C Fitting C Adib-Conquy M. Endotoxin tolerance: is there a clinical relevance? J Endotoxin Res. 2003; 9(2):101–107.
48. Pollock EM Ford-Jones EL Rebeyka I, et al. Early noscomial infections in pediatric cardiovascular surgery patients. Crit Care Med. 1990; 18(4):378–384.
49. Opal SM Cohen J. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Crit Care Med. 1999; 27(8):1608–1616.
50. Moine P Abraham E. Immunomodulation and sepsis: impact of the pathogen. Shock. 2004; 22(4):297–308.
51. van der Poll T Opal SM. Host-pathogen interactions in sepsis. Lancet Infect Dis. 2008; 8(1):32–43.
52. Cooke GS Hill AV. Genetics of susceptibility to human infectious disease. Nat Rev Genet. 2001; 2(12):967–977.
53. Cornell TT Wynn J Shanley TP Wheeler DS Wong HR. Mechanisms and regulation of the gene-expression response to sepsis. Pediatrics. 2010; 125(6):1248–1258.
54. Wheeler DS Wong HR. Genetic approach to pediatric septic shock. Personalized Med. 2008; 5(2):249–263.
55. Sorensen TI Nielsen GG Andersen PK Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med. 1988; 318(12):727–732.
56. Osuchowski MF Welch K Siddiqui J Remick DG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol. 2006; 177(3):1967–1974.
57. Ashare A Powers LS Butler NS Doerschug KC Monick MM Hunninghake GW. Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am J Physiol Lung Cell Mol Physiol. 2005; 288(4):L633–L640.
58. Docke WD Randow F Syrbe U, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med. 1997; 3(6):678–681.
59. Volk HD Reinke P Krausch D, et al. Monocyte deactivation–rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 1996; 22(suppl 4):S474–S481.
60. Kox WJ Bone RC Krausch D, et al. Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle. Arch Intern Med. 1997; 157(4):389–393.
61. Bundschuh DS Barsig J Hartung T, et al. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. J Immunol. 1997; 158(6):2862–2871.
62. Pugin J. Immunostimulation is a rational therapeutic strategy in sepsis. Novartis Found Symp. 2007; 280: 21-36, 160-164.
63. Nelson LA. Use of granulocyte-macrophage colony-stimulating factor to reverse anergy in otherwise immunologically healthy children. Ann Allergy Asthma Immunol. 2007; 98(4):373–382.
64. Spight D Trapnell B Zhao B, et al. Granulocyte-macrophage-colony-stimulating factor-dependent peritoneal macrophage responses determine survival in experimentally induced peritonitis and sepsis in mice. Shock. 2008; 30(4):434–442.
65. Flohe SB Agrawal H Flohe S Rani M Bangen JM Schade FU. Diversity of interferon gamma and granulocyte-macrophage colony-stimulating factor in restoring immune dysfunction of dendritic cells and macrophages during polymicrobial sepsis. Mol Med. 2008; 14(5-6):247–256.
66. Monneret G Venet F Pachot A Lepape A. Monitoring immune dysfunctions in the septic patient: A new skin for the old ceremony. Mol Med. 2008; 14(1-2):64–78.
67. Kaplan JM Wong HR. Biomarker discovery and development in pediatric critical care medicine. Pediatr Crit Care Med. 2011;12:165-173;
68. Wong HR Wheeler DS Tegtmeyer K, et al. Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept. Crit Care Med. 2010; 38(10):1955–1961.
69. Seghaye MC Engelhardt W Grabitz RG, et al. Multiple system organ failure after open heart surgery in infants and children. Thorac Cardiovasc Surg. 1993; 41(1):49–53.
70. Shime N Kageyama K Ashida H Tanaka Y. Application of modified sequential organ failure assessment score in children after cardiac surgery. J Cardiothorac Vasc Anesth. 2001; 15(4):463–468.
71. Ben-Abraham R Efrati O Mishali D, et al. Predictors for mortality after prolonged mechanical ventilation after cardiac surgery in children. J Crit Care. 2002; 17(4):235–239.
72. Arora P Kher V Rai PK Singhal MK Gulati S Gupta A. Prognosis of acute renal failure in children: a multivariate analysis. Pediatr Nephrol. 1997; 11(2):153–155.
73. Bunchman TE McBryde KD Mottes TE Gardner JJ Maxvold NJ Brophy PD. Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol. 2001; 16(12):1067–1071.
74. Otukesh H Hoseini R Hooman N, et al. Prognosis of acute renal failure in children. Pediatr Nephrol. 2006; 21(5):1873–1878.
75. Zappitelli M Bernier PL Saczkowski RS, et al. A small post-operative rise in serum creatinine predicts acute kidney injury in children undergoing cardiac surgery. Kidney Int. 2009; 76(8):885–892.
76. Carcillo JA Fields AI. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med. 2002; 30(6):1365–1378.
77. Han YY Carcillo JA Dragotta MA, et al. Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics. 2003; 112(4):793–799.
78. Oliveira CF Nogueira de Sa FR Oliveira DS, et al. Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: Barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world. Pediatr Emerg Care. 2008; 24(12):810–815.
79. de Oliveira CF de Oliveira DS Gottschald AF, et al. ACCM/PALS haemodynamic support guidelines for paediatric septic shock: An outcomes comparison with and without monitoring of central venous oxygen saturation. Intensive Care Med. 2008; 34(6):1065–1075.
80. Brierley J Carcillo JA Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009; 37(4):666–688.